{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:52:20Z","timestamp":1772945540281,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2321-B-006-012-"],"award-info":[{"award-number":["NSTC 114-2321-B-006-012-"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jmii.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T23:16:19Z","timestamp":1754522179000},"page":"701-707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bloodstream infections in hospitalized adults with COVID-19: clinical characteristics and outcomes"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0518-7365","authenticated-orcid":false,"given":"Po-Hsuan","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-3833","authenticated-orcid":false,"given":"Ling-Shan","family":"Syue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching\u2010Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5925-920X","authenticated-orcid":false,"given":"Bo-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0336-682X","authenticated-orcid":false,"given":"Sheng-Jie","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-842X","authenticated-orcid":false,"given":"Nan-Yao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.08.002_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2025.08.002_bib2","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1093\/cid\/ciaa1748","article-title":"Risk factors and outcomes of hospitalized patients with severe coronavirus disease 2019 (COVID-19) and secondary bloodstream infections: a multicenter case-control study","volume":"72","author":"Bhatt","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3904\/kjim.2022.084","article-title":"Clinical outcomes of and risk factors for secondary infection in patients with severe COVID-19: a multicenter cohort study in South Korea","volume":"38","author":"Na","year":"2023","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jmii.2025.08.002_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13054-023-04312-0","article-title":"COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation","volume":"27","author":"Patton","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2025.08.002_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s12879-018-3548-0","article-title":"The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09","volume":"18","author":"MacIntyre","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12879-022-07942-x","article-title":"Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis","volume":"23","author":"Calderon","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13319","article-title":"Bloodstream infections in critically ill patients with COVID\u201019","volume":"50","author":"Giacobbe","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jmii.2025.08.002_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00134-021-06346-w","article-title":"COVID-19 increased the risk of ICU-acquired bloodstream infections: a case\u2013cohort study from the multicentric outcomerea network","volume":"47","author":"Buetti","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jmii.2025.08.002_bib10","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012560","article-title":"SARS\u2010CoV\u20102, bacterial co\u2010infections, and AMR: the deadly trio in COVID\u201019?","volume":"12","author":"Bengoechea","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jmii.2025.08.002_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fmed.2020.00420","article-title":"Secondary bacterial infections in patients with viral pneumonia","volume":"7","author":"Manohar","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jmii.2025.08.002_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09959-w","article-title":"Impact of SARS-CoV-2 viral load on restrictive spirometry patterns in mild COVID-19 recovered middle-aged individuals: a six-month prospective study","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib13","first-page":"468","article-title":"Cycle threshold values predict COVID-19 severity and mortality but are not correlated with laboratory markers","volume":"22","author":"Esmaeili","year":"2023","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jmii.2025.08.002_bib14","unstructured":"M100 | Performance Standards for Antimicrobial Susceptibility Testing. https:\/\/clsi.org\/shop\/standards\/m100\/(accessed 21 April 2025)."},{"key":"10.1016\/j.jmii.2025.08.002_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-024-04963-7","article-title":"Prompt antimicrobial therapy and source control on survival and defervescence of adults with bacteraemia in the emergency department: the faster, the better","volume":"28","author":"Lee","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2025.08.002_bib16","unstructured":"WHO-2019-nCoV-clinical-2020.5-eng.pdf. https:\/\/iris.who.int\/bitstream\/handle\/10665\/332196\/WHO-2019-nCoV-clinical-2020.5-eng.pdf?sequence=1 (accessed 23 March 2025)."},{"key":"10.1016\/j.jmii.2025.08.002_bib17","unstructured":"Clinical Guidance for COVID-19 Vaccination | CDC. 2025.https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html (accessed 5 April 2025)."},{"key":"10.1016\/j.jmii.2025.08.002_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01028-23","article-title":"Laboratory approaches to determining blood culture contamination rates: an ASM laboratory practices subcommittee report","volume":"62","author":"Palavecino","year":"2024","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2025.08.002_bib19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/cid\/ciz535","article-title":"Resilience of the Pitt bacteremia score: 3 decades and counting","volume":"70","author":"Al Hasan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2025.08.002_bib21","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1080\/10428194.2021.1876865","article-title":"Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort","volume":"62","author":"Bhogal","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmii.2025.08.002_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jmii.2021.09.015","article-title":"Changing epidemiology and prognosis of nosocomial bloodstream infection: a single-center retrospective study in Taiwan","volume":"55","author":"Liao","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2025.08.002_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10096-024-04755-5","article-title":"Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections","volume":"43","author":"Duan","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jmii.2022.09.006","article-title":"Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: incidence, diagnosis and treatment","volume":"55","author":"Wu","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2025.08.002_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/eurpub\/ckad060","article-title":"Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study","volume":"33","author":"L\u00f3pez-Herrero","year":"2023","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jmii.2025.08.002_bib26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40121-022-00636-6","article-title":"Clinical characteristics associated with bacterial bloodstream coinfection in COVID-19","volume":"11","author":"Rebold","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jmii.2025.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.08.002_bib28","doi-asserted-by":"crossref","first-page":"e1082","DOI":"10.1093\/cid\/ciab869","article-title":"Changing patterns of bloodstream infections in the community and acute care across 2 coronavirus disease 2019 epidemic waves: a retrospective analysis using data linkage","volume":"75","author":"Zhu","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib29","first-page":"1965","article-title":"Bloodstream coinfections and antimicrobial resistance in hospitalized COVID-19 patients: a single-center retrospective study","volume":"38","author":"Tsai","year":"2024"},{"key":"10.1016\/j.jmii.2025.08.002_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID\u201019 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2025.08.002_bib31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jmii.2024.07.014","article-title":"Clinical characteristics and outcomes of patients with candidemia during the COVID-19 pandemic: insights from experience in the Omicron era","volume":"57","author":"Lin","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2025.08.002_bib32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.002_bib33","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cmi.2024.09.011","article-title":"Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study","volume":"30","author":"Loiodice","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2025.08.002_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmii.2022.12.003","article-title":"Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan","volume":"56","author":"Wu","year":"2023","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:12:15Z","timestamp":1772892735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225001501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1684118225001501"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.08.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bloodstream infections in hospitalized adults with COVID-19: clinical characteristics and outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}